8-K
LAM RESEARCH CORP (LRCX)
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 23, 2025
LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 0-12933 | 94-2634797 |
|---|---|---|
| (State or Other Jurisdiction<br>of Incorporation) | (Commission<br>File Number) | (IRS Employer<br>Identification Number) |
4650 Cushing Parkway
Fremont, California 94538
(Address of principal executive offices including zip code)
(510) 572-0200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered |
|---|---|---|
| Common Stock, Par Value $0.001 Per Share | LRCX | The Nasdaq Stock Market |
| (Nasdaq Global Select Market) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Table of Contents
Table of Contents
| Item 2.02. | Results of Operations and Financial Condition | 3 |
|---|---|---|
| Item 9.01. | Financial Statements and Exhibits | 3 |
| SIGNATURES | 4 | |
| EX-99.1 |
Table of Contents
| Item 2.02. | Results of Operations and Financial Condition |
|---|
On April 23, 2025, Lam Research Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended March 30, 2025, the text of which is attached hereto as Exhibit 99.1.
The information in this item of this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. Furthermore, the information in this item of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
| Item 9.01. | Financial Statements and Exhibits |
|---|
(d) Exhibits
| 99.1 | Press Release dated April 23, 2025 announcing financial results for the fiscal quarter ended March 30, 2025 |
|---|---|
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document |
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: | April 23, 2025 | LAM RESEARCH CORPORATION |
|---|---|---|
| (Registrant) | ||
| /s/ Douglas R. Bettinger | ||
| Douglas R. Bettinger | ||
| Executive Vice President and Chief Financial Officer | ||
| (Principal Financial Officer) |
Document
Exhibit 99.1
FOR IMMEDIATE RELEASE
Lam Research Corporation Reports Financial Results for the Quarter Ended March 30, 2025
FREMONT, Calif., April 23, 2025 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended March 30, 2025 (the “March 2025 quarter”).
Highlights for the March 2025 quarter were as follows:
•Revenue of $4.72 billion.
•U.S. GAAP gross margin of 49.0%, U.S. GAAP operating income as a percentage of revenue of 33.1%, and U.S. GAAP diluted EPS of $1.03.
•Non-GAAP gross margin of 49.0%, non-GAAP operating income as a percentage of revenue of 32.8%, and non-GAAP diluted EPS of $1.04.
Key Financial Data for the Quarters Ended
March 30, 2025 and December 29, 2024
(in thousands, except per-share data, percentages, and basis points)
| U.S. GAAP | |||||||
|---|---|---|---|---|---|---|---|
| March 2025 | December 2024 | Change Q/Q | |||||
| Revenue | $ | 4,720,175 | $ | 4,376,047 | + 8% | ||
| Gross margin as percentage of revenue | 49.0 | % | 47.4 | % | + 160 bps | ||
| Operating income as percentage of revenue | 33.1 | % | 30.5 | % | + 260 bps | ||
| Diluted EPS | $ | 1.03 | $ | 0.92 | + 12% | ||
| Non-GAAP | |||||||
| March 2025 | December 2024 | Change Q/Q | |||||
| Revenue | $ | 4,720,175 | $ | 4,376,047 | + 8% | ||
| Gross margin as percentage of revenue | 49.0 | % | 47.5 | % | + 150 bps | ||
| Operating income as percentage of revenue | 32.8 | % | 30.7 | % | + 210 bps | ||
| Diluted EPS | $ | 1.04 | $ | 0.91 | + 14% |
U.S. GAAP Financial Results
For the March 2025 quarter, revenue was $4,720 million, gross margin was $2,314 million, or 49.0% of revenue, operating expenses were $752 million, operating income was 33.1% of revenue, and net income was $1,331 million, or $1.03 per diluted share on a U.S. GAAP basis. This compares to revenue of $4,376 million, gross margin of $2,073 million, or 47.4% of revenue, operating expenses of $739 million, operating income of 30.5% of revenue, and net income of $1,191 million, or $0.92 per diluted share, for the quarter ended December 29, 2024 (the “December 2024 quarter”).
Non-GAAP Financial Results
For the March 2025 quarter, non-GAAP gross margin was $2,312 million, or 49.0% of revenue, non-GAAP operating expenses were $763 million, non-GAAP operating income was 32.8% of revenue, and non-GAAP net income was $1,336 million, or $1.04 per diluted share. This compares to non-GAAP gross margin of $2,077 million, or 47.5% of revenue, non-GAAP operating expenses of $735 million, non-GAAP operating income of 30.7% of revenue, and non-GAAP net income of $1,175 million, or $0.91 per diluted share, for the December 2024 quarter.
“Lam’s portfolio is the most compelling it’s ever been, driving opportunities to expand our addressable market, gain share, and deliver innovative services as deposition and etch intensity increases in the production of advanced semiconductors,” said Tim Archer, Lam Research's President and Chief Executive Officer. “Our outlook remains strong even as we address near-term tariff-related uncertainty, and we are highly confident in our ability to outperform semiconductor industry growth in the years to come.”
Balance Sheet and Cash Flow Results
Cash, cash equivalents, and restricted cash balances decreased to $5.5 billion at the end of the March 2025 quarter compared to $5.7 billion at the end of the December 2024 quarter. The decrease was primarily the result of cash deployed for capital return activities, principal payment on debt instruments, and capital expenditures during the quarter, partially offset by cash generated from operating activities.
Deferred revenue at the end of the March 2025 quarter decreased to $2,011 million compared to $2,032 million as of the end of the December 2024 quarter. Lam's deferred revenue balance does not include shipments to customers in Japan, to whom control does not transfer until customer acceptance. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $587 million as of March 30, 2025 and $453 million as of December 29, 2024.
Revenue
The geographic distribution of revenue during the March 2025 quarter is shown in the following table:
| Region | Revenue |
|---|---|
| China | 31% |
| Korea | 24% |
| Taiwan | 24% |
| Japan | 10% |
| United States | 4% |
| Southeast Asia | 4% |
| Europe | 3% |
The following table presents revenue disaggregated between system and customer support-related revenue:
| Three Months Ended | ||||||
|---|---|---|---|---|---|---|
| March 30,<br>2025 | December 29,<br>2024 | March 31,<br>2024 | ||||
| (In thousands) | ||||||
| Systems revenue | $ | 3,035,276 | $ | 2,625,649 | $ | 2,395,817 |
| Customer support-related revenue and other | 1,684,899 | 1,750,398 | 1,397,741 | |||
| $ | 4,720,175 | $ | 4,376,047 | $ | 3,793,558 |
Systems revenue includes sales of new leading-edge equipment in deposition, etch, clean and other wafer fabrication markets.
Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.
Outlook
For the quarter ended June 29, 2025, Lam is providing the following guidance:
| U.S. GAAP | Reconciling Items | Non-GAAP | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.00 Billion | +/- | $300 Million | — | $5.00 Billion | +/- | $300 Million | ||
| Gross margin as a percentage of revenue | 49.4% | +/- | 1% | $ | 2.7 | Million | 49.5% | +/- | 1% |
| Operating income as a percentage of revenue | 33.4% | +/- | 1% | $ | 3.2 | Million | 33.5% | +/- | 1% |
| Net income per diluted share | $1.20 | +/- | $0.10 | $ | 3.7 | Million | $1.20 | +/- | $0.10 |
| Diluted share count | 1.28 Billion | — | 1.28 Billion |
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or realized after the date of this release, except as described below. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:
•Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $2.7 million.
•Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $3.2 million.
•Net income per diluted share - amortization related to intangible assets acquired though business combinations, $3.2 million; amortization of debt discounts, $0.7 million; and associated tax benefit for non-GAAP items ($0.2 million); totaling $3.7 million.
Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the March 2025 and December 2024 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the net income tax effect of non-GAAP items. Additionally, the non-GAAP results for the December 2024 quarter exclude the income tax benefit from a change in tax law.
Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at https://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating income and net income; our opportunities, including with respect to our addressable market, share and delivery of services; trends with respect to deposition and etch intensity in semiconductor production; the strength of our outlook; our ability to address the impacts of tariff-related uncertainty; the duration of tariff-related uncertainty; our confidence in our outlook; our relative performance compared the future performance of the industry; and the prospects for future industry growth. Some factors that may affect these forward-looking statements include: business, economic, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; trade regulations, export controls, tariffs, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; supply chain cost increases, tariffs and other inflationary pressures have impacted and may continue to impact our profitability; supply chain disruptions or manufacturing capacity constraints may limit our ability to manufacture and sell our products; and natural and human-caused disasters, disease outbreaks, war, terrorism, political or governmental unrest or instability, or other events beyond our control may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10-K for the fiscal year ended June 30, 2024, and our quarterly report on Form 10-Q for the fiscal quarter ended December 29, 2024. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.
Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX)
Consolidated Financial Tables Follow.
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
(unaudited)
| Three Months Ended | Nine Months Ended | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 30,<br>2025 | December 29,<br>2024 | March 31,<br>2024 | March 30,<br>2025 | March 31,<br>2024 | |||||||||||
| Revenue | $ | 4,720,175 | $ | 4,376,047 | $ | 3,793,558 | $ | 13,264,198 | $ | 11,033,879 | |||||
| Cost of goods sold | 2,406,489 | 2,303,066 | 1,977,820 | 6,874,848 | 5,783,087 | ||||||||||
| Restructuring charges, net - cost of goods sold | — | — | 15,202 | — | 38,099 | ||||||||||
| Total cost of goods sold | 2,406,489 | 2,303,066 | 1,993,022 | 6,874,848 | 5,821,186 | ||||||||||
| Gross margin | 2,313,686 | 2,072,981 | 1,800,536 | 6,389,350 | 5,212,693 | ||||||||||
| Gross margin as a percent of revenue | 49.0 | % | 47.4 | % | 47.5 | % | 48.2 | % | 47.2 | % | |||||
| Research and development | 525,904 | 494,947 | 512,274 | 1,516,209 | 1,404,615 | ||||||||||
| Selling, general and administrative | 226,023 | 244,150 | 215,904 | 713,301 | 651,770 | ||||||||||
| Restructuring charges, net - operating expenses | — | — | 15,246 | — | 18,955 | ||||||||||
| Total operating expenses | 751,927 | 739,097 | 743,424 | 2,229,510 | 2,075,340 | ||||||||||
| Operating income | 1,561,759 | 1,333,884 | 1,057,112 | 4,159,840 | 3,137,353 | ||||||||||
| Operating income as a percent of revenue | 33.1 | % | 30.5 | % | 27.9 | % | 31.4 | % | 28.4 | % | |||||
| Other income (expense), net | (25,035) | 14,262 | 36,073 | 19,308 | 68,513 | ||||||||||
| Income before income taxes | 1,536,724 | 1,348,146 | 1,093,185 | 4,179,148 | 3,205,866 | ||||||||||
| Income tax expense | (206,057) | (157,128) | (127,359) | (541,019) | (398,376) | ||||||||||
| Net income | $ | 1,330,667 | $ | 1,191,018 | $ | 965,826 | $ | 3,638,129 | $ | 2,807,490 | |||||
| Net income per share: | |||||||||||||||
| Basic | $ | 1.04 | $ | 0.93 | $ | 0.74 | $ | 2.82 | $ | 2.13 | |||||
| Diluted | $ | 1.03 | $ | 0.92 | $ | 0.73 | $ | 2.81 | $ | 2.12 | |||||
| Number of shares used in per share calculations: | |||||||||||||||
| Basic | 1,283,779 | 1,287,109 | 1,308,382 | 1,290,041 | 1,316,627 | ||||||||||
| Diluted | 1,288,100 | 1,291,469 | 1,315,178 | 1,294,545 | 1,322,819 | ||||||||||
| Cash dividend declared per common share | $ | 0.23 | $ | 0.23 | $ | 0.20 | $ | 0.69 | $ | 0.60 |
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
| March 30,<br>2025 | December 29,<br>2024 | June 30,<br>2024 | ||||
|---|---|---|---|---|---|---|
| (unaudited) | (unaudited) | (1) | ||||
| ASSETS | ||||||
| Cash and cash equivalents | $ | 5,450,718 | $ | 5,665,379 | $ | 5,847,856 |
| Accounts receivable, net | 3,228,182 | 3,304,946 | 2,519,250 | |||
| Inventories | 4,463,275 | 4,358,152 | 4,217,924 | |||
| Prepaid expenses and other current assets | 318,147 | 284,370 | 298,190 | |||
| Total current assets | 13,460,322 | 13,612,847 | 12,883,220 | |||
| Property and equipment, net | 2,372,203 | 2,313,590 | 2,154,518 | |||
| Goodwill and intangible assets | 1,795,248 | 1,761,021 | 1,765,073 | |||
| Other assets | 2,340,537 | 2,152,458 | 1,941,917 | |||
| Total assets | $ | 19,968,310 | $ | 19,839,916 | $ | 18,744,728 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||
| Current portion of long-term debt and finance lease obligations | $ | 754,306 | $ | 504,136 | $ | 504,814 |
| Other current liabilities | 4,735,539 | 4,846,160 | 3,833,624 | |||
| Total current liabilities | 5,489,845 | 5,350,296 | 4,338,438 | |||
| Long-term debt and finance lease obligations | 3,730,034 | 4,478,148 | 4,478,520 | |||
| Income taxes payable | 690,660 | 669,747 | 813,304 | |||
| Other long-term liabilities | 546,666 | 533,699 | 575,012 | |||
| Total liabilities | 10,457,205 | 11,031,890 | 10,205,274 | |||
| Stockholders’ equity (2) | 9,511,105 | 8,808,026 | 8,539,454 | |||
| Total liabilities and stockholders’ equity | $ | 19,968,310 | $ | 19,839,916 | $ | 18,744,728 |
| (1) | Derived from audited financial statements. | |||||
| --- | --- | |||||
| (2) | Common shares issued and outstanding were 1,282,957 as of March 30, 2025, 1,284,956 as of December 29, 2024, and 1,303,769 as of June 30, 2024. |
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
| Three Months Ended | Nine Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| March 30,<br>2025 | December 29,<br>2024 | March 31,<br>2024 | March 30,<br>2025 | March 31,<br>2024 | ||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||||
| Net income | $ | 1,330,667 | $ | 1,191,018 | $ | 965,826 | $ | 3,638,129 | $ | 2,807,490 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
| Depreciation and amortization | 97,343 | 96,200 | 89,922 | 287,838 | 271,342 | |||||
| Deferred income taxes | (19,992) | (82,854) | (24,621) | (211,568) | (137,606) | |||||
| Equity-based compensation expense | 87,115 | 81,959 | 76,854 | 249,085 | 213,966 | |||||
| Other, net | 1,654 | (8,592) | 10,210 | (7,395) | 14,242 | |||||
| Changes in operating assets and liabilities | (188,124) | (535,789) | 266,645 | (337,013) | 620,405 | |||||
| Net cash provided by operating activities | 1,308,663 | 741,942 | 1,384,836 | 3,619,076 | 3,789,839 | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||||
| Capital expenditures and intangible assets | (288,058) | (188,349) | (103,654) | (586,995) | (295,922) | |||||
| Net maturities and sales of available-for-sale securities | — | — | 14,650 | — | 37,766 | |||||
| Other, net | (4,857) | 12,974 | (3,356) | 8,154 | (10,845) | |||||
| Net cash used for investing activities | (292,915) | (175,375) | (92,360) | (578,841) | (269,001) | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||||
| Principal payments on debt, including finance lease obligations and payments for debt issuance costs | (504,037) | (1,032) | (1,060) | (506,003) | (255,155) | |||||
| Treasury stock purchases, including excise tax payments | (435,321) | (697,688) | (980,561) | (2,130,044) | (2,469,257) | |||||
| Dividends paid | (295,716) | (297,634) | (262,707) | (854,335) | (757,453) | |||||
| Reissuance of treasury stock related to employee stock purchase plan | — | 60,557 | — | 60,557 | 53,081 | |||||
| Proceeds from issuance of common stock, net issuance costs | 1,993 | (194) | 8,235 | 1,756 | 12,757 | |||||
| Other, net | 526 | 761 | 300 | 963 | (5,672) | |||||
| Net cash used for financing activities | (1,232,555) | (935,230) | (1,235,793) | (3,427,106) | (3,421,699) | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 2,380 | (26,022) | (8,452) | (960) | (12,758) | |||||
| Net change in cash, cash equivalents, and restricted cash | (214,427) | (394,685) | 48,231 | (387,831) | 86,381 | |||||
| Cash, cash equivalents, and restricted cash at beginning of period (1) | 5,677,399 | 6,072,084 | 5,625,522 | 5,850,803 | 5,587,372 | |||||
| Cash, cash equivalents, and restricted cash at end of period (1) | $ | 5,462,972 | $ | 5,677,399 | $ | 5,673,753 | $ | 5,462,972 | $ | 5,673,753 |
| (1) | Restricted cash is reported within Other assets in the Condensed Consolidated Balance Sheets | |||||||||
| --- | --- |
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
| Three Months Ended | ||||||
|---|---|---|---|---|---|---|
| March 30,<br>2025 | December 29,<br>2024 | |||||
| Revenue | $ | 4,720,175 | $ | 4,376,047 | ||
| Gross margin | $ | 2,312,391 | $ | 2,077,151 | ||
| Gross margin as percentage of revenue | 49.0 | % | 47.5 | % | ||
| Operating expenses | $ | 763,336 | $ | 734,501 | ||
| Operating income | $ | 1,549,055 | $ | 1,342,650 | ||
| Operating income as a percentage of revenue | 32.8 | % | 30.7 | % | ||
| Net income | $ | 1,336,006 | $ | 1,175,000 | ||
| Net income per diluted share | $ | 1.04 | $ | 0.91 | ||
| Shares used in per share calculation - diluted | 1,288,100 | 1,291,469 |
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited)
| Three Months Ended | ||||
|---|---|---|---|---|
| March 30,<br>2025 | December 29,<br>2024 | |||
| U.S. GAAP net income | $ | 1,330,667 | $ | 1,191,018 |
| Pre-tax non-GAAP items: | ||||
| Amortization related to intangible assets acquired through certain business combinations - cost of goods sold | 2,687 | 2,817 | ||
| Elective deferred compensation ("EDC") related liability valuation (decrease) increase - cost of goods sold | (3,982) | 1,353 | ||
| EDC related liability valuation (decrease) increase - research and development | (7,168) | 2,432 | ||
| Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative | 538 | 538 | ||
| EDC related liability valuation (decrease) increase - selling, general and administrative | (4,779) | 1,626 | ||
| Amortization of note discounts - other income (expense), net | 759 | 772 | ||
| Loss (gain) on EDC related asset - other income (expense), net | 16,903 | (4,502) | ||
| Net income tax expense (benefit) on non-GAAP items | 381 | (276) | ||
| Income tax benefit from a change in tax law | — | (20,778) | ||
| Non-GAAP net income | $ | 1,336,006 | $ | 1,175,000 |
| Non-GAAP net income per diluted share | $ | 1.04 | $ | 0.91 |
| U.S. GAAP net income per diluted share | $ | 1.03 | $ | 0.92 |
| U.S. GAAP and non-GAAP number of shares used for per diluted share calculation | 1,288,100 | 1,291,469 |
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited)
| Three Months Ended | ||||||
|---|---|---|---|---|---|---|
| March 30,<br>2025 | December 29,<br>2024 | |||||
| U.S. GAAP gross margin | $ | 2,313,686 | $ | 2,072,981 | ||
| Pre-tax non-GAAP items: | ||||||
| Amortization related to intangible assets acquired through certain business combinations | 2,687 | 2,817 | ||||
| EDC related liability valuation (decrease) increase | (3,982) | 1,353 | ||||
| Non-GAAP gross margin | $ | 2,312,391 | $ | 2,077,151 | ||
| U.S. GAAP gross margin as a percentage of revenue | 49.0 | % | 47.4 | % | ||
| Non-GAAP gross margin as a percentage of revenue | 49.0 | % | 47.5 | % | ||
| U.S. GAAP operating expenses | $ | 751,927 | $ | 739,097 | ||
| Pre-tax non-GAAP items: | ||||||
| Amortization related to intangible assets acquired through certain business combinations | (538) | (538) | ||||
| EDC related liability valuation decrease (increase) | 11,947 | (4,058) | ||||
| Non-GAAP operating expenses | $ | 763,336 | $ | 734,501 | ||
| U.S. GAAP operating income | $ | 1,561,759 | $ | 1,333,884 | ||
| Non-GAAP operating income | $ | 1,549,055 | $ | 1,342,650 | ||
| U.S. GAAP operating income as percent of revenue | 33.1 | % | 30.5 | % | ||
| Non-GAAP operating income as a percent of revenue | 32.8 | % | 30.7 | % |
Lam Research Corporation Contacts:
Ram Ganesh, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com